7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 
      
    		                     
      assets
    		                     
      current assets:
    		                     
      cash and cash equivalents
    		238,554,000 297,872,000 211,526,000 104,862,000 93,775,000 28,434,000 61,294,000 71,425,000 23,792,000 42,116,000 70,969,000 348,607,000 121,971,000     103,386,000 102,194,000 66,417,000 21,270,000 
      restricted cash
    		321,000 319,000 318,000 325,000 323,000 320,000 317,000     300,000,000          
      short-term investments
    		  149,789,000 307,487,000 393,122,000 297,035,000 95,386,000 114,817,000 175,153,000 172,898,000 170,963,000           
      prepaid expenses and other current assets
    		7,591,000 11,049,000 9,118,000 10,519,000 2,410,000 2,052,000 5,323,000               
      total current assets
    		246,466,000 309,240,000 370,751,000 423,750,000 490,290,000 328,794,000 163,265,000 189,712,000 204,951,000 227,501,000 248,027,000 656,712,000 137,119,000 79,398,000 99,435,000 97,312,000 102,210,000 121,482,000 125,217,000 87,674,000 42,077,000 
      non-current assets:
    		                     
      property and equipment
    		810,000 690,000 652,000 254,000 265,000 223,000 181,000 204,000 229,000 225,000 412,000 906,000 930,000 1,095,000 965,000 694,000 656,000 757,000 684,000 725,000  
      operating lease right-of-use assets
    		5,420,000 5,552,000 6,351,000 7,144,000                  
      goodwill
    		1,999,000 2,039,000 1,923,000 1,864,000 1,991,000 1,880,000 1,875,000 1,893,000 1,814,000 1,883,000 1,839,000 1,798,000 1,655,000 1,806,000 1,953,000 2,009,000 2,001,000 2,057,000 2,047,000 2,030,000 2,335,000 
      other assets
    		7,034,000 6,516,000 4,145,000 1,850,000 1,863,000 1,879,000 1,875,000 4,322,000 4,332,000 254,000 156,000 577,000 140,000 179,000 166,000 170,000      
      total assets
    		261,729,000 324,037,000 383,822,000 435,560,000 502,852,000 341,856,000 176,781,000 202,949,000 218,476,000 237,372,000 254,897,000 664,168,000 155,327,000 95,718,000 116,472,000 113,374,000 128,673,000 145,517,000 140,794,000 102,498,000 56,865,000 
      liabilities and stockholders' equity
    		                     
      current liabilities:
    		                     
      accounts payable
    		22,245,000 22,982,000 4,994,000 4,636,000 3,252,000 3,340,000 6,371,000 2,667,000 3,314,000 987,000 710,000 355,000 1,431,000 3,574,000 6,959,000 4,374,000 5,875,000 6,949,000 4,114,000 6,140,000 2,493,000 
      accrued liabilities
    		27,042,000 26,148,000 21,185,000 19,554,000 18,477,000 12,457,000 6,547,000 8,783,000    10,664,000    7,197,000    4,261,000  
      accrued compensation
    		10,965,000 6,592,000 4,396,000 11,977,000 7,961,000 4,877,000 6,033,000 5,429,000 3,510,000 3,529,000 2,416,000 5,641,000 2,509,000 1,906,000 1,514,000 4,125,000      
      operating lease liabilities, current portion
    		2,720,000 3,118,000 3,543,000 3,765,000                  
      other current liabilities
    		1,956,000 1,485,000 759,000 1,797,000 1,027,000 806,000 788,000 717,000 484,000 619,000 320,000 662,000 209,000 265,000 678,000 897,000 1,030,000 661,000 581,000 729,000 354,000 
      total current liabilities
    		64,928,000 60,325,000 34,877,000 41,729,000 59,009,000 140,168,000 23,438,000 20,405,000 113,742,000 11,931,000 17,443,000 38,782,000 16,682,000 15,173,000 22,724,000 25,623,000 22,789,000 21,888,000 73,052,000 19,890,000 14,742,000 
      non-current liabilities:
    		                     
      operating lease liabilities, net of current portion
    		2,708,000 2,435,000 2,907,000 3,453,000                  
      other non-current liabilities
    		1,830,000 1,838,000 1,708,000 1,630,000 1,716,000 1,596,000 3,310,000 1,562,000 1,476,000 1,511,000 1,481,000 1,429,000 2,424,000 2,594,000 2,751,000 2,776,000 2,690,000 2,689,000 2,603,000 2,511,000 2,277,000 
      total liabilities
    		69,466,000 64,598,000 39,492,000 46,812,000 64,932,000 146,781,000 132,571,000 125,257,000 119,097,000 117,773,000 121,415,000 537,514,000 22,079,000 44,401,000 52,065,000 30,090,000 26,375,000 26,090,000 76,389,000 23,045,000 20,004,000 
      commitments and contingencies
    		                     
      stockholders' equity:
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at september 30, 2025 and december 31, 2024, respectively
    		                     
      common stock
    		7,444,000 7,428,000 7,416,000 7,376,000 7,371,000 7,243,000 7,020,000 7,017,000 6,978,000 6,976,000 6,976,000 2,110,000 2,013,000 981,000 981,000 980,000 976,000 974,000 829,000 826,000 672,000 
      additional paid-in capital
    		2,262,515,000 2,097,957,000 1,616,963,000 1,598,230,000 1,586,227,000 1,287,447,000 1,076,370,000 1,066,381,000 1,051,415,000 1,050,483,000 1,048,608,000 504,767,000 493,553,000 391,220,000 388,328,000 384,049,000 377,213,000 373,882,000 295,129,000 293,367,000 242,395,000 
      accumulated other comprehensive loss
    		-2,709,000 -2,752,000 -2,563,000 -2,285,000 -2,308,000 -2,499,000 -2,449,000 -2,448,000 -2,323,000 -2,437,000 -1,396,000 -1,893,000 -3,217,000 -3,168,000 -3,957,000 -2,197,000 -3,442,000 -2,579,000 -3,119,000 -3,794,000 -7,032,000 
      accumulated deficit
    		-2,074,987,000 -1,843,194,000 -1,277,486,000 -1,214,573,000 -1,153,370,000 -1,097,116,000 -1,036,731,000 -993,258,000 -956,691,000 -935,423,000 -920,706,000 -378,330,000 -359,101,000 -337,716,000 -320,945,000 -299,548,000 -272,449,000 -252,850,000 -228,434,000 -210,946,000 -199,174,000 
      total stockholders' equity
    		192,263,000 259,439,000 344,330,000 388,748,000 437,920,000 195,075,000 44,210,000  99,379,000 119,599,000 133,482,000 126,654,000 133,248,000 51,317,000 64,407,000 83,284,000 102,298,000 119,427,000 64,405,000 79,453,000 36,861,000 
      total liabilities and stockholders' equity
    		261,729,000 324,037,000 383,822,000 435,560,000 502,852,000 341,856,000 176,781,000  218,476,000 237,372,000 254,897,000 664,168,000 155,327,000 95,718,000 116,472,000 113,374,000 128,673,000 145,517,000 140,794,000 102,498,000 56,865,000 
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at june 30, 2025 and december 31, 2024, respectively
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at march 31, 2025 and december 31, 2024, respectively
    		                     
      research and development tax credit receivable
    		   557,000 660,000 953,000 945,000 848,000 812,000 4,607,000 4,500,000 5,766,000 12,958,000 14,132,000 15,290,000 15,695,000 10,072,000   9,856,000  
      liabilities and stockholders’ equity
    		                     
      promissory note payable to a related party
    		    24,500,000 100,000,000 100,000,000  100,000,000     25,312,000 25,055,000    54,963,000   
      stockholders’ equity:
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at december 31, 2024 and 2023, respectively
    		                     
      right-of-use assets
    		    7,976,000 8,716,000 9,373,000 5,859,000 6,403,000 6,996,000 3,928,000 4,175,000 4,230,000 2,017,000 2,432,000 2,790,000 1,884,000 2,212,000 1,487,000 554,000 628,000 
      lease liabilities
    		    3,792,000 3,688,000 3,699,000 2,809,000 2,780,000 2,928,000 1,693,000 1,690,000 1,392,000 684,000 907,000 1,091,000 941,000 1,006,000 1,056,000 390,000 386,000 
      lease liabilities, net of current portion
    		    4,207,000 5,017,000 5,823,000 3,290,000 3,879,000 4,331,000 2,491,000 2,763,000 2,973,000 1,322,000 1,535,000 1,691,000      
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at september 30, 2024 and december 31, 2023, respectively
    		                     
      accrued acquired in-process research and development
    		     15,000,000                
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at june 30, 2024 and december 31, 2023, respectively
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at march 31, 2024 and december 31, 2023, respectively
    		                     
      accounts receivable
    		           349,000 140,000 238,000 870,000 1,464,000 2,290,000 1,053,000 447,000  4,080,000 
      prepaid expenses
    		       2,441,000 5,074,000 6,093,000 1,186,000 1,504,000 1,622,000 5,393,000 4,350,000 7,161,000 8,409,000 5,727,000 7,995,000 9,547,000 7,141,000 
      other current assets
    		       181,000 120,000 1,787,000 409,000 486,000 428,000 2,300,000 1,475,000 1,201,000 1,191,000 963,000 985,000 1,523,000 1,667,000 
      promissory note payable to related parties
    		           19,770,000          
      non-current liabilities
    		                     
      promissory notes payable to related parties
    		       100,000,000    494,540,000          
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at december 31, 2023 and 2022, respectively
    		                     
      total stockholders’ equity
    		       77,692,000              
      total liabilities and stockholders’ equity
    		       202,949,000              
      accrued expenses
    		        3,654,000 3,868,000 12,304,000  11,141,000 5,513,000 7,569,000  7,432,000 6,132,000 4,915,000  4,398,000 
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at september 30, 2023 and december 31, 2022, respectively
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at june 30, 2023 and december 31, 2022, respectively
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at march 31, 2023 and december 31, 2022, respectively
    		                     
      intangible assets
    		            7,952,000 8,900,000 9,866,000 10,399,000 10,608,000 11,161,000 11,359,000 11,515,000 11,101,000 
      deferred revenue and other income
    		             3,231,000 5,097,000 7,939,000      
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at december 31, 2022 and 2021, respectively
    		                     
      preferred stock, 0.01 par value, 20,000,000 shares authorized; none issued and outstanding at september 30, 2022 and december 31, 2021, respectively
    		                     
      cash
    		             57,335,000 77,450,000 71,791,000 80,248,000     
      preferred stock, 0.01 par value, 20,000,000 shared authorized; none issued and outstanding at june 30, 2022 and december 31, 2021, respectively
    		                     
      deferred revenue and other income, net of current portion
    		                     
      deferred revenue
    		                7,511,000     
      research and development tax credit receivables
    		                 10,353,000 13,596,000  7,919,000 
      deferred revenue and income
    		                 7,140,000 7,423,000 8,370,000  
      accounts and other receivable
    		                   331,000  
      contingent consideration
    		                     
      current assets
    		                     
      property, plant and equipment
    		                    724,000 
      current liabilities
    		                     
      deferred income
    		                    7,111,000 
      deferred tax liability
    		                    2,108,000 
      stockholders'equity
    		                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.